Substance / Medication

Fosfestrol tetrasodium

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Diagnostic accuracy of multiparametric MRI for detecting unconventional prostate cancer histology: a systematic review and meta-analysis.
Carletti Filippo, Maggi Martina, Fazekas Tamas et al. · Eur Radiol · 2026
PMID: 40307530Meta-AnalysisFull text (PMC)
Chinese medicines as therapeutic options for treating prostate cancer: Therapeutic effects and underlying mechanisms.
Li Shenglong, Jing Shuaishuai, Zhou Jiuyun et al. · J Ethnopharmacol · 2026
PMID: 40882785Meta-Analysis
Hormone Therapy With Salvage Radiotherapy After Radical Prostatectomy: A Systematic Review and Meta-Analysis.
Bayani Reyhaneh, Kolahdouzan Kasra, Nayebirad Sepehr et al. · Prostate · 2026
PMID: 40985821Meta-Analysis
Addition of androgen-receptor pathway inhibitors to standard of care in metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis.
Maiorano Brigida Anna, Mercinelli Chiara, Cigliola Antonio et al. · Urol Oncol · 2026
PMID: 41006128Meta-Analysis
Influence of 5-Alpha Reductase Inhibitors on PI-RADS Scores and Prostate Cancer Detection: A Systematic Review and Meta-Analysis.
Qiong Lian, Qingyi Li, Bohong Guo et al. · Prostate · 2026
PMID: 41017157Meta-Analysis
The role of PSMA PET/CT in staging patients with intermediate-risk prostate cancer.
Bonaddio Jacinta, Carll Jonathon, Eapen Renu et al. · BJU Int · 2026
PMID: 41025962Meta-AnalysisFull text (PMC)
Transperineal versus Transrectal Prostate Biopsy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Suartz Caio Vinicius, Santos Lucas Amorim, Matalani Caio Felipe Araujo et al. · Clin Genitourin Cancer · 2026
PMID: 41385931Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Fosfestrol tetrasodium (substance)
SNOMED CT
396066003
UMLS CUI
C0919270

Clinical Data

This intervention maps to 3 entities in the Healos knowledge graph.

3
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.